这是一种新的血小板生成剂治疗儿童免疫性血小板减少症(ITP)的首例研究成果。
This is the first publication of the results of one of the new thrombopoietic agents in the treatment of children with immune thrombocytopenia (ITP).
目的探讨脾脏射频消融术治疗顽固性免疫性血小板减少症(itp)的安全性和有效性。
Objective to assess the safety and efficacy of radiofrequency ablation of the spleen for intractable immune thrombocytopenia (ITP).
应用推荐